NASOMETRY DEVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• In June 2022, Vivos Therapeutics Inc, a medical technology company focused on developing treatments for patients suffering from dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults, announced that it had entered into an exclusive distribution agreement with GM Instruments Ltd., a medical device company, for the distribution of GM Instruments’ NR6 Rhinomanometer, in the U.S. used to calculate nasal airway resistance by measuring nasal flow and the pressure producing that flow. Under the terms of agreements, Vivos Therapeutics Inc became the distributor of NR6 Rhinomanometer.